Davide Marotta, Ph.D.: Science on the International Space Station
Release Date: 05/29/2025
ReGEN Podcast
Dana Levin, MD, MPH, serves as the medical director and chief flight surgeon for Vast Space. As the International Space Station plans for decommission in 2030, Vast Space is an industry pioneer with developing the first commercial space station, Haven-1, for long-term human habitation of low Earth orbit. We discuss the implications of humans inhabiting space in this new frontier of opportunities, challenges, questions and implications for human health and medicine. Dana’s background before his role at Vast includes working for NASA as a clinical scientist for the human research program,...
info_outlineReGEN Podcast
Our conversation this week is with Bruce Y. Lee, MD, MBA, a digital health and AI expert whose research focuses on AI systems modeling and other computer-aided approaches within the healthcare industry. Bruce has founded, built, and led multiple initiatives in systems science, AI, mathematical and computer modeling, digital health, operations research and science/health communications, including research consortia, centers at universities and independent companies. Hosted by Bobby Gordon, MA, MBA This episode was recorded on Oct. 15, 2025, and information presented herein is current at the...
info_outlineReGEN Podcast
Our conversation with Alysson Muotri, PhD, covers a broad scope of topics including his innovative work and discoveries in space-based research, Neanderthal DNA, and groundbreaking breakthroughs in regenerative medicine and indigenous plants found in the Amazon Rainforest. Muotri serves as the director of the Sanford Integrated Space Stem Cell Orbital Research Center (ISSCOR) at UC San Diego’s Sanford Stem Cell Institute, leading numerous research missions in sustained microgravity and low-Earth orbit. His work includes a focus on generating human disease models to determine the...
info_outlineReGEN Podcast
This episode features our conversation with Tiffani Manolis, vice president and general manager of the cell biology business at Thermo Fisher Scientific. Our discussion highlights her passion for cell biology and innovative trends in the gene and cell therapy industry, with a focus on advancing technologies that support the development of life-changing therapeutics. Tiffani is an experienced leader in the life sciences industry in her current role and joined Thermo Fisher Scientific in 2022 to lead the cell culture and cell therapy business. Prior to this role, Tiffani held various leadership...
info_outlineReGEN Podcast
Our conversation with Gene Yeo, PhD, MBA, features a deep dive into his innovative work with RNA, gene editing and intersection of stem cells and regenerative medicine. We discuss what’s on the horizon for discoveries and industry-based opportunities. Yeo serves as the director of the Sanford Stem Cell Innovation Center with the goal to facilitate industry growth by leveraging research findings and developed technologies to support the commercialization of applications through strategic collaboration with industry partners. Yeo’s work focuses on high-throughput genomics, systems biology...
info_outlineReGEN Podcast
This episode features our conversation with Julissa Gonzalez, MS, who serves as the clinical research data manager at the UC San Diego Sanford Stem Cell Clinical Center. Her work helps frame and prepare insights into stem cell-related clinical trials. Our discussion explores information the public may not readily know about preparing for and administering therapeutics via clinical trials, including unique perspectives on validation, analyses, and patient care outcomes. This episode was recorded on June 2, 2025, and information is current as of the date of this recording. Hosted by Bobby...
info_outlineReGEN Podcast
Marisa Korody, PhD, serves San Diego Zoo Wildlife Alliance as a scientist in conservation genetics, working on the northern white rhino rescue project. She works closely with collaborators at The Scripps Research Institute to optimize the production of induced pluripotent stem cells (iPSCs) from banked rhino fibroblast cells in the Frozen Zoo® for potential use in assisted reproductive technologies. This episode was recorded on Aug. 13, 2025, and information is current as of the date of recording. Hosted by Bobby Gordon, MA, MBA.
info_outlineReGEN Podcast
This episode features our conversation with Alexis Komor, PhD, who serves as deputy director of the Sanford Stem Cell Innovation Center and assistant professor in the Department of Chemistry and Biochemistry at UC San Diego. Not long after the discovery of CRISPR technology, Komor Identified how to edit DNA in a new, more precise way, down to a single base unit in the DNA sequence. Komor’s contributions in teaching, mentoring, and research have been recognized with many awards, including the Cottrell Scholar Award, the “Talented 12” recognition by C&EN News, an NSF Faculty...
info_outlineReGEN Podcast
This episode features a conversation Dan Kaufman, PhD, Director of the Sanford Advanced Therapy Center at the Sanford Stem Cell Institute, and his extensive background in the field of regenerative medicine. At UC San Diego, Dr. Kaufman performs clinical work in hematology and blood and marrow transplantation. He also oversees the Advanced Cell Therapy Laboratory (ACTL), a cGLP/cGMP-compliant facility which provides good manufacturing practice and cell manufacturing to translate new cell-based therapies to clinical trials; to help investigators advance cell therapy products from research...
info_outlineReGEN Podcast
Our discussion in this episode features Alex Khalessi, MD, MBA, and his innovative work on the intersection between stem cell therapies, regenerative medicine, and neurological disorders. He serves as co-director of the Brain Tumor and Neurorestoration Program at the Sanford Stem Cell Institute. Khalessi is the former president of the Congress of Neurological Surgeons (CNS), and is chair of the Department of Neurological Surgery, professor of neurological surgery, radiology and neurosciences and the inaugural Don and Karen Cohn Chancellor’s Endowed Chair in Neurosurgery at UC San...
info_outlineThe Sanford Stem Cell Institute’s Bobby Gordon sits down with Davide Marotta, Ph.D., program director of in-space biomanufacturing at the International Space Station National Laboratory (ISSNL), to discuss the innovative low-Earth orbit economy and the future of science in space. We also discuss ISSNL's collaborations with UC San Diego's Sanford Stem Cell Institute.
Before joining the ISSNL in 2022, Dr. Marotta worked as a scientist at the New York Stem Cell Foundation, where his research focused on developing advanced models of neurodegenerative diseases using induced pluripotent stem cell (iPSC)-derived brain organoids and tracking the effects of microgravity on them.
He received both bachelor’s and master’s of science degrees in biomedicine from the University of Palermo in Italy, and a Ph.D. in molecular and cell biology at University College London. He conducted post-doctoral research at the Institute of Cancer Research in London, where he worked on drug discovery and cancer evolution, and Columbia University in New York, where his research centered on hematopoietic stem cells and aging.
Dr. Marotta is the author of the newly released book “The Gravity of Innovation.” Published in April 2025, it explores the revolutionary impact of space on science, technology, and industry.
Hosted by Bobby Gordon, MA, MBA. This episode was recorded Oct. 15, 2024; information presented was current as of the date of recording.